Rethinking drug design in the artificial intelligence era

Schneider, Petra; Walters, W. Patrick; Sieroka, Norman; Listgarten, Jennifer; Goodnow Jr., Robert A.; Fisher, Jasmin; Jansen, Johanna M.; Duca, José S.; Rush, Thomas S.; Zentgraf, Matthias; Hill, John Edward; Krutoholow, Elizabeth; Kohler, Matthias; Blaney, Jeff; Funatsu, Kimito; Luebkemann, Chris; Schneider, Gisbert

doi:10.1038/s41573-019-0050-3

Metadata only

Datum

2020-05

Typ

Journal Article

Zitate

222 Zitate in Web of Science

249 Zitate in Scopus

ETH Bibliographie

yes

Altmetrics

Publikationsstatus

published

Externe Links

https://doi.org/10.1038/s41573-019-0050-3

Zeitschrift / Serie

Nature Reviews Drug Discovery

Band

19(5)

Seiten / Artikelnummer

353 - 364

Verlag

Nature Publishing Group

Thema

Computational chemistry; Drug development; Drug screening; Drug therapy; Small molecules

Organisationseinheit

03709 - Kohler, Matthias / Kohler, Matthias
02284 - NFS Digitale Fabrikation / NCCR Digital Fabrication
03852 - Schneider, Gisbert / Schneider, Gisbert

Mehr

Alle Metadaten anzeigen

Zitate

222 Zitate in Web of Science

249 Zitate in Scopus

ETH Bibliographie

yes

Altmetrics

Research Collection

Suche

Rethinking drug design in the artificial intelligence era Mendeley CSV RIS BibTeX

Rethinking drug design in the artificial intelligence era

Mendeley

CSV

RIS

BibTeX